Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and …

…, RC Ahrens, DR Hess, P Anderson, R Dhand… - Chest, 2005 - Elsevier
Background The proliferation of inhaler devices has resulted in a confusing number of
choices for clinicians who are selecting a delivery device for aerosol therapy. There are …

[HTML][HTML] Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2

R Dhand, J Li - American journal of respiratory and critical care …, 2020 - atsjournals.org
The slogan “Coughs and Sneezes Spread Diseases” was coined in the United States during
the last great flu pandemic between 1918 and 1920 to highlight the role of coughs and …

Aerosol drug delivery: developments in device design and clinical use

MB Dolovich, R Dhand - The Lancet, 2011 - thelancet.com
Aerosolised drugs are prescribed for use in a range of inhaler devices and systems. Delivering
drugs by inhalation requires a formulation that can be successfully aerosolised and a …

Phosphatidylinositol-3-OH kinase direct target of Ras

P Rodriguez-Viciana, PH Warne, R Dhand… - Nature, 1994 - nature.com
Ras (p21 ras ) interacts directly with the catalytic subunit of phosphatidylinositol-3-OH kinase
in a GTP-dependent manner through the Ras effector site. In vivo, dominant negative Ras …

Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase

…, D Malek, S Stoyanova, B Vanhaesebroeck, R Dhand… - Science, 1995 - science.org
Phosphoinositide-3 kinase activity is implicated in diverse cellular responses triggered by
mammalian cell surface receptors and in the regulation of protein sorting in yeast. Receptors …

What the pulmonary specialist should know about the new inhalation therapies

…, FHC de Jongh, SG Devadason, R Dhand… - 2011 - Eur Respiratory Soc
A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was
facilitated by the European Respiratory Society (ERS) and the International Society for …

Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit

ID Hiles, M Otsu, S Volinia, MJ Fry, I Gout, R Dhand… - Cell, 1992 - Elsevier
Purified bovine brain phosphatidylinositol 3-kinase (PI3-kinase) is composed of 85 kd and
110 kd subunits. The 85 kd subunit (p85α) lacks PI3-kinase activity and acts as an adaptor, …

Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase

…, F Ruiz-Larrea, G Panayotou, A Thompson, R Dhand… - Cell, 1991 - cell.com
Affinity-purified bovine brain phosphatidylinositol 3-kinase (PI3-kinase) contains two major
proteins of 85 and 110 kd. Amino acid sequence analysis and cDNA cloning reveals two …

PI 3‐kinase: structural and functional analysis of intersubunit interactions.

R Dhand, K Hara, I Hiles, B Bax, I Gout… - The EMBO …, 1994 - embopress.org
… Indeed, monoclonal antibodies that have epitopes located in the N-terminal SH2 domain
of p85a do not inhibit the binding of pl 10 to the p85 subunits (R.Dhand, unpublished …

A human phosphatidylinositol 3‐kinase complex related to the yeast Vps34p‐Vps15p protein sorting system.

S Volinia, R Dhand, B Vanhaesebroeck… - The EMBO …, 1995 - embopress.org
Phosphoinositide (PI) 3‐kinases have been characterized as enzymes involved in receptor
signal transduction in mammalian cells and in a complex which mediates protein trafficking …